Advanced Drug Delivery Systems: Crossing the Blood-Brain Barrier

One of the major challenges in Alzheimer’s treatment is the delivery of therapeutic agents across the blood-brain barrier (BBB). This track will explore cutting-edge drug delivery systems designed to overcome this barrier, such as nanoparticle-based systems, liposomal carriers, and other targeted delivery technologies. Discussions will include how these innovations can improve the efficacy of drugs targeting Alzheimer’s pathology.
 

    Related Conference of Advanced Drug Delivery Systems: Crossing the Blood-Brain Barrier

    October 24-25, 2024

    13th World congress on Addictive Disorders & Addiction Therapy

    Zurich, Switzerland
    February 17-18, 2025

    42nd Global Psychiatry and Mental Health Conference

    Paris, France
    February 20-21, 2025

    5th World Conference on Addiction Psychiatry

    Amsterdam, Netherlands
    February 24-25, 2025

    6th Annual Congress on Psychiatry

    London, UK
    March 10-11, 2025

    5th Annual Congress on Mental Health

    Paris, France
    March 10-11, 2025

    7th International Congress on Mental Health

    Paris, France
    April 07-08, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    April 14-15, 2025

    3rd World Congress on Psychiatry

    Budapest, Hungary
    May 21-22, 2025

    7th European Autism Congress

    Paris, France
    June 16-17, 2025

    3rd International Conference onPsychiatry and Psychology

    Zurich, Switzerland
    June 16-17, 2025

    10th International Conference on Addiction Therapy

    Zurich, Switzerland
    June 16-17, 2025

    35th Euro Congress on Psychiatrists and Psychologists

    Frankfurt, Germany

    Advanced Drug Delivery Systems: Crossing the Blood-Brain Barrier Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in